Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Marked variation in the suscep...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Marked variation in the susceptibility of HIV-1 to type 1 interferon inhibition during early, late and rebound infection

Marked variation in the susceptibility of HIV-1 to type 1 interferon inhibition during early, late and rebound infection

Bibliographic Details
Main Authors: M. Gondim, S. Sherrill-Mix, M. Saag, M. Nussenzweig, J. Silicano, P. Sharp, P. Borrow, L. Montaner, K. Bar, B. Hahn
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020301485
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2055664020301485

Similar Items

  • Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
    by: Gondim, MVP, et al.
    Published: (2021)
  • Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness
    by: Iyer, S, et al.
    Published: (2017)
  • The utility of rebound tonometer in late elderly subjects
    by: Sakata R, et al.
    Published: (2014-01-01)
  • To rebound or not to rebound
    by: Bethany A Stahl, et al.
    Published: (2017-10-01)
  • Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
    by: P. Zacharopoulou, et al.
    Published: (2022-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs